Intelligent Ultrasound Share Discussion Threads

[40 fathoms] 07/5/2023 08:06

Mentions SonoLyst

[bamboo2] 06/5/2023 11:05

10 min in, Joanne Hart [MoS] discusses IUG



"They are going places, GE use their tech, was technically oversold."

Nothing new.

[bamboo2] 05/5/2023 20:56

AI is increasingly being used in healthcare to reduce clinician workloads and improve patient outcomes. AI-driven technologies are helping to automate mundane tasks, freeing up clinicians to focus on more complex clinical decisions. Importantly, this may also help reduce clinician burnout. AI-powered tools can also help identify patterns in medical data that can lead to faster diagnoses and better patient outcomes.

h ttps://www.medgadget.com/2023/05/ais-role-in-healthcare-exclusive-interview-with-catherine-estrampes-president-ceo-at-ge-healthcare.html

[bamboo2] 05/5/2023 20:51

LOS ANGELES (PRWEB) MAY 03, 2023

MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global health and medical technology market, today announced that it has selected GE HealthCare, a leading global precision health care innovator, as a winner in the 7th annual MedTech Breakthrough Awards program. The company was awarded “Best New Ultrasound Technology Solution” recognizing the breakthrough innovation of the Voluson™ Expert 22 Women’s Health ultrasound system.

Performing detailed exams with high-resolution can provide early insights into fetal health. By identifying fetal abnormalities earlier, clinicians can intervene sooner, plan for delivery, and potentially improve outcomes.

Both intuitive and customizable, the Voluson™ Expert 22 provides ultra-premium ultrasound imaging that increases exam speed and accuracy through its use of graphic-based beamformer technology and artificial intelligence (AI). The result is higher quality images and greater flexibility in workflow and imaging functions.

The Voluson™ Expert 22 features Lyric Architecture, which allows for more data and works in concert with specialized probe technology to unlock new imaging and processing power. This enables faster, sharper and clearer images and increased independence from body habitus (differing shape and size of the human body) and other difficult scanning conditions. By generating new levels of penetration, resolution, and frame rates to reveal fine anatomy in 2D/3D/4D with ease, the system delivers uniformity throughout the image with increased spatial and contrast resolution.

Clinicians can also make use of SonoLyst*, a virtual on-board tool that uses AI to automatically help identify fetal anatomy seen on standard views while enhancing efficiency by adding annotations and measurements. For quality assurance, SonoLyst can also be used to compare the image or view acquired to standard criteria helping ensure exam quality and consistency needed due to the shortage of skilled labor. Additionally, the system boasts Respond, a workflow enhancer that uses probe activation sensors to automatically initialize probes and presets when removed from the probe holder.

“Voluson™; Ultrasound products have a long-standing reputation of providing state-of-the-art technology for women’s health. We developed the Voluson™ Expert 22 from the ground-up to re-invent ultrasound, taking into account the current and future needs of clinicians providing precision diagnosis,” said Gerald Seifriedsberger, General Manager, Women’s Health Ultrasound, GE HealthCare. “We are therefore delighted to accept this award from MedTech Breakthrough, and pledge to continue to drive daily imaging efficiencies and innovate in women’s health.”

The mission of the MedTech Breakthrough Awards is to honor excellence and recognize the innovation, hard work and success in a range of health and medical technology categories, including Telehealth, Clinical Administration, Patient Engagement, Electronic Health Records (EHR), Virtual Care, Medical Devices, Medical Data and many more. This year’s program attracted more than 4,000 nominations from over 17 different countries throughout the world.

“Complex pregnancies demand advanced tools so clinicians can quickly and precisely diagnose or monitor a patient’s condition, and clinicians need a smart, intuitive medical ultrasound imaging system that can help them overcome workforce and training challenges. The breakthrough Voluson™ Expert 22 delivers on this need,” said James Johnson, managing director, MedTech Breakthrough. “With its unique features, clinicians can uncover critical answers sooner, discover key insights, and simplify complex cases for faster assessment, detection, and diagnosis. Congratulations to GE HealthCare on winning the ‘Best New Ultrasound Technology Solution” award for 2023.”

*SonoLyst incorporates the AI technology of Intelligent Ultrasound.

[bamboo2] 05/5/2023 18:49

jurgens,

Yes, anytime in the next three weeks or so for it to perform as a flag or pennant.

Quite a few trades late reported at 16p

Not sure when they are delayed from, today or yesterday?

Think they must be buys.

[jurgensredarmy] 05/5/2023 12:38

Don’t think it will get there today but I’m happy to just wait and let the story unfold here. Huge potential on offer here.

[bamboo2] 05/5/2023 07:31

An eod close above 16.7 would confirm a new target price at 22.4

[jurgensredarmy] 04/5/2023 13:57

Added a lump yesterday which sits nicely in my ISA

[bamboo2] 03/5/2023 17:01

Added a few more this afternoon, to replace some of those sold recently.

[joseph moran] 02/5/2023 13:28

I reckon this drop is profit taking after big rise last week.

[bamboo2] 28/4/2023 19:54

The chief executive of a Cardiff-based ultrasound company, which specialises in artificial intelligence software and simulation, has highlighted the firm's intention to more than double turnover by 2025.

Stuart Gall, of Intelligent Ultrasound, was speaking after revenue grew by 33 per cent to £10.1m from £7.6m in its latest results for the year ended 31 December 2022.

Now Gall is aiming for turnover to be £25m in just two years as the business, which has a US base in Atlanta and a China, Japan & Asia Pacific presence in Beijing, continues to grow.

Speaking to Insider, he said: "We're looking to extend the business in the clinical AI side. This year we've taken the simulation revenue and grown that and grew the AI revenue by 200 per cent.

"We're starting to show traction in AI to £700,000 revenue and that's forecast to go to £2m revenue.

"In terms of simulation, the beginning of Covid made people more aware of how important ultrasound was to scan properly, and we've seen strong sales in the UK and the market continue to grow.

"So we're aiming for £25m turnover by 2025 and everything this year is about keeping on the path to this."

Audited results for the firm saw simulation-related revenue increase by 28 per cent to £9.4m from £7.4m the previous year, driven by strong sales in the UK.

Clinical AI-related revenue rose by more than 200 per cent to £700,000 compared to £200,000 the year before. Loss after tax for the group reduced to £2.98m from £3.6m in 2021.

Next article: Record growth for Welsh executive search business

Previous article: £2.4m funding for empty homes

Year-end cash was at £7.2m compared to £5m the prior period, after a £4.8m placing (net of fees) and no debt (excluding IFRS 16 lease liabilities).

Other highlights included the group achieving the "important" milestone of FDA clearance for its second AI-driven product and continue to build a partnership with ultrasound company - GE HealthCare.

Now the group expects to continue growth during 2023 and remain "excited" about the long-term potential of its unique 'Classroom to Clinic' model."

Gall said the business has no further plans for a placing and would focus on taking its current product range forward, although he said it would keep an eye out for acquisition opportunities.

He added: "There's no need to raise any more money by a placing and we will look to take to company product range forward.

"Of course if there's a quality acquisition opportunity, we'd consider it."

[eeza] 28/4/2023 19:09

Very satisfying when all goes to plan :-)


ONT next.

[bamboo2] 28/4/2023 18:39

Hit first target, so sold 100,000 today.

Have quite a few left in ISA and SIPP.

[eeza] 28/4/2023 18:23

Can't keep a good dog down.

[bamboo2] 28/4/2023 18:03

Ding dong!

[eeza] 27/4/2023 08:30

Yes, looks to have great potential. When everyone has their own personal handheld U/S scanner, then d/load pics to Hospital for analysis.

God knows what else they're working on !

[bamboo2] 27/4/2023 07:49

Eeza, worth a look at the product on you tube. It's quite something.

[eeza] 26/4/2023 20:45

Amazing that it has all kicked off following a newspaper pundit tip, (~7.50p and falling before) and which has supplied the neccessary liquidity.

[bamboo2] 26/4/2023 20:33

cheers eeza.

Price has picked up every afternoon for the past few sessions. Could this be US based interest?

[eeza] 26/4/2023 18:20

Looks like an Insti, to me, looking at the trades.


Come on, ONT (lagging).

[bamboo2] 26/4/2023 18:05

Flag min 15.2p min target confirmed.

Price rising above rising 50/100/200 smas. [This was last seen in Nov 2021]

Additionally, an INVH&S pattern confirmed with a min tp at 16.2p

We either have an insti taking a position or there is some corporate activity in the offing.

[gsbmba99] 26/4/2023 08:27

From GEHC's 10-Q (
"On February 17, 2023, the Company acquired 100% of the stock of Caption Health, Inc. (“Caption Health”) for $127 million of upfront payment, $10 million future holdback payment and potential earn-out payments valued at $13 million based primarily on various milestones and sales targets. The preliminary purchase price allocation resulted in goodwill of $105 million, intangible assets of $60 million, and deferred tax liabilities of $14 million. The goodwill associated with the acquired business is non-deductible for tax purposes and is reported in the Ultrasound segment. Caption Health is an artificial intelligence (“AI”) company whose technology expands access to AI-guided ultrasound screening for novice users."

[bamboo2] 24/4/2023 13:47

Major IUG customer, GEHC will be updating the market tomorrow.
They should give guidance on Ultrasound sales, which may allow extrapolation to the outlook over here.
There is also t/o potential.

========================================================================

GE HealthCare (Nasdaq: GEHC), a leader in precision care innovation, will announce its first quarter 2023 financial results before the market opens on Tuesday, April 25, 2023.

The GE HealthCare management team will also host a conference call and webcast at 8:00 a.m. Eastern Time on that same day, which will be a live webcast and accessible at...



The earnings release, accompanying financial information, and webcast replay will also all be posted at the same link on the GE HealthCare Investor Relations website.